Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Monash IVF Group Announces Appointment of CEO/MD and CFO/Company Secretary

15 Apr 2019  |  13:55:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Appointment of CEO/MD and CFO/Company Secretary

Monash IVF Group announced that it has appointed Mr. Michael Knaap as CEO and MD effective immediately. Mr. Knaap was appointed the interim CEO in October 2018 following his tenure as Monash IVF Group's Chief Financial Officer and Company Secretary since August 2015. Mr. Knaap has nearly 20 years experience in executive positions with a strong operational, strategic and leadership background. Following Mr. Knaap's appointment, the Company also announced the appointment of Mr. Malik Jainudeen as CFO and Company Secretary, replacing Mr. Knaap as Company Secretary.

Please click here for full details

See more ASX300 News Announcements